WallStreetZenWallStreetZen

NASDAQ: CHRS
Coherus Oncology Inc Stock Ownership - Who owns Coherus Oncology?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Coherus Oncology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Mats WahlstromDirector2025-05-2399,988$0.74
$73.89kSell
Dennis M. LanfearPresident CEO2025-01-2011,810$1.39
$16.42kSell
Paul ReiderChief Commercial Officer2025-01-204,858$1.39
$6.75kSell
Bryan J. McMichaelChief Financial Officer2025-01-201,711$1.39
$2.38kSell
Bryan J. McMichaelChief Financial Officer2025-01-071,711$1.57
$2.69kSell
Dennis M. LanfearPresident CEO2025-01-0411,810$1.66
$19.60kSell
Paul ReiderChief Commercial Officer2025-01-042,277$1.66
$3.78kSell
Paul ReiderChief Commercial Officer2024-12-132,073$1.61
$3.34kSell

1 of 1

CHRS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CHRS insiders and whales buy or sell their stock.

CHRS Shareholders

What type of owners hold Coherus Oncology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc9.26%10,739,710$18.04MInstitution
Vanguard Group Inc9.12%10,570,515$17.76MInstitution
Vsciences Investments Pte Ltd6.37%7,381,116$12.40MInsider
Tang Capital Management LLC4.40%5,097,362$8.56MInstitution
Lilly Co Eli2.62%3,042,019$5.11MInsider
Kohlberg Kravis Roberts Co LP2.62%3,036,076$5.10MInstitution
Daiichi Sankyo Company Ltd2.47%2,867,426$4.82MInsider
Geode Capital Management LLC2.31%2,676,476$4.50MInstitution
Dennis M. Lanfear2.21%2,563,451$4.31MInsider
Kkr Biosimilar LP2.16%2,499,499$4.20MInsider

1 of 3

CHRS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CHRS47.75%18.07%Net Selling
GNFT0.11%0.00%
SLS25.42%8.22%Net Buying
EPRX5.48%0.00%
OABI44.85%26.84%Net BuyingNet Buying
View Top Biotech Stocks

Coherus Oncology Stock Ownership FAQ

Who owns Coherus Oncology?

Coherus Oncology (NASDAQ: CHRS) is owned by 47.75% institutional shareholders, 18.07% Coherus Oncology insiders, and 34.18% retail investors. Vsciences Investments Pte Ltd is the largest individual Coherus Oncology shareholder, owning 7.38M shares representing 6.37% of the company. Vsciences Investments Pte Ltd's Coherus Oncology shares are currently valued at $12.40M.

If you're new to stock investing, here's how to buy Coherus Oncology stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.